for PCO formation is the proliferation of residual lens epithelial cells, which attach to and migrate along the lens surface.
The current standard therapy for after-cataract is photodisruption of the posterior capsule by Nd:YAG laser, which can be associated with significant complications. Alternative lens designs with sharp edges were not able to significantly reduce overall cataract surgical costs. The numerous pharmacological approaches to prevent posterior capsule opacification have not led to clinical success.
A novel non-toxic coating with alkylphosphocholines for ophthalmological implants significantly reduces proliferation of residual lens epithelial cells and the resulting posterior capsule opacification. The coated lens could be implanted in a standard cataract surgery setting without additional requirements.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
firstname.lastname@example.org | TechnologieAllianz e.V.
New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.
Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
23.08.2017 | Materials Sciences
23.08.2017 | Automotive Engineering
23.08.2017 | Life Sciences